APGE

Apogee Therapeutics
$134.28
$0.00 (0%)Jul 27, 2026
4.3NeutralMoatMint rating

MoatMint rates Apogee Therapeutics (APGE) 4.3 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 0.7 out of 10.

Key metrics

The numbers that frame APGE today
Market cap
$10.12B
P/E (TTM)
-36.9
EV / FCF
-41.1
ROIC
-42%
Div yield
0%
Debt / equity
0.0
52wk Low
$34.34
52wk High
$134.46

APGE stock rating

How APGE scores on quality, value, growth, momentum and financial health
4.3out of 10
Neutral overallFair business, expensive priceTop 57% of ~5,000 US stocks
QualityPoor0.7/10
GrowthNeutral4.4/10
MomentumGreat9.7/10
ValueFair3.3/10
Financial HealthGood6.7/10

Growth

Revenue and earnings trend for APGE
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about APGE
Is Apogee Therapeutics a good buy?
Hold. Apogee Therapeutics has excellent momentum, but poor quality makes the setup mixed. Growth looks weak. That could put pressure on the long-term business case. We think Apogee Therapeutics is selling at a high price.
What is the market capitalization of APGE?
Apogee Therapeutics's market capitalization is $10.12B.
What is the P/E ratio for APGE stock?
Apogee Therapeutics's current P/E ratio is -36.9.
What is the 52-week high for APGE stock?
The 52-week high for Apogee Therapeutics is $134.46. The current close of $134.28 is 0.1% below that high.
What is the 52-week low for APGE stock?
The 52-week low for Apogee Therapeutics is $34.34. The current close of $134.28 is 291% above that low.
Does APGE stock pay dividends?
Apogee Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for APGE?
Apogee Therapeutics's Debt / Equity ratio is 0.01.